3

FORM 3 SUBMISSION

Company: Corvus Pharmaceuticals, Inc.
Filed: March 22, 2016
Period of Report: March 22, 2016
Accession Number: 0001209191-16-110089

View Document ↗ View on SEC.gov ↗